Early Intravenous Delivery of Human Brain Stromal Cells Modulates Systemic Inflammation and Leads to Vasoprotection in Traumatic Spinal Cord Injury
This study demonstrates that these cells not only display a MSC phenotype in vitro but also have similar in vivo immunomodulatory effects after spinal cord injury that are more potent than those of non-central nervous system tissue-derived cells. Therefore, these cells are of great interest for therapeutic use in spinal cord injury.
Source: Stem Cells Translational Medicine - Category: Stem Cells Authors: Badner, A., Vawda, R., Laliberte, A., Hong, J., Mikhail, M., Jose, A., Dragas, R., Fehlings, M. Tags: Mesenchymal Stem Cells, Fetal and Neonatal Stem Cells Source Type: research
More News: Brain | Hemorrhagic Stroke | Liver | Liver Transplant | Lung Transplant | Neurology | Neuroscience | Pathology | Perinatology & Neonatology | Spinal Cord Injury | Stem Cell Therapy | Stem Cells | Study | Transplants | Urology & Nephrology